InvestSMART

Breville Group Limited (ASX:BRG)

ALERT: Price-sensitive ASX Announcement for BRG
Current share price for BRG : $32.850 -0.25 (-0.76%)+
Release
19 Aug 2026 7:53AM
Price at Release
$33.100
Full Release
download
Summary
The annual report for Breville Group Limited for the year ending 30 June 2026 indicates a financial year marked by increased revenue and gross profit. Total revenue increased to $1,810.9 million, with a gross profit of $651.4 million, maintaining a consistent gross margin. Net profit from continuing operations was reported at $117.8 million, with the total comprehensive income impacted by adverse foreign currency translations. The company strengthened its equity through increased issued capital, with strategic share issuances while maintaining robust dividends. The report highlights significant revenue from its Global Product and Distribution segments across major geographic markets.
Key Points
  • Breville Group Limited reported a total revenue increase from $1,696,551,000 in 2025 to $1,810,896,000 in 2026.
  • Gross profit for the year ended 30 June 2026 was $651,383,000, with a gross margin of 36.0%.
  • The company’s net assets stood at $1,058,305,000 as of 30 June 2026.
  • Net profit attributable to Breville Group Limited owners from continuing operations for the year was $117,754,000.
  • Total comprehensive income for the year included a foreign currency translation reserve decrease and a cash flow hedge increase, resulting in other comprehensive income of -$20,373,000.
  • Breville Group Limited issued capital increased by $16,911,000 due to shares issued for performance and deferred remuneration plans.
  • The company declared dividends amounting to $55,038,000 for the year.
  • Breville Group's operating segments include Global Product and Distribution, with significant revenue contributions from the Americas, EMEA, and APAC regions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.